Meta-analysis is a statistical framework that aggregates summary statistics from multiple independent genome-wide association studies (GWAS) to produce a single, more precise estimate of a genetic variant's effect on a phenotype. By pooling data across cohorts, it dramatically increases the effective sample size, enabling the detection of variants with smaller effect sizes that individual studies lack the statistical power to identify.
Glossary
Meta-Analysis
A statistical technique that combines summary statistics from multiple independent GWAS to increase statistical power for variant discovery and improve the generalizability of derived polygenic scores.
STATISTICAL GENOMICS
What is Meta-Analysis?
A statistical technique that combines summary statistics from multiple independent GWAS to increase statistical power for variant discovery and improve the generalizability of derived polygenic scores.
The process requires rigorous harmonization of effect alleles, genomic coordinates, and phenotype definitions across studies, often using fixed-effects or random-effects models weighted by sample size or inverse variance. This technique is foundational for constructing robust polygenic risk scores (PRS), as the combined effect sizes from a trans-ethnic meta-analysis improve the cross-ancestry portability and generalizability of predictive models beyond a single homogeneous cohort.
GWAS SUMMARY STATISTICS INTEGRATION
Key Characteristics of Meta-Analysis
Meta-analysis aggregates effect sizes from multiple independent GWAS cohorts to boost statistical power, enabling the discovery of novel loci and providing more robust base data for polygenic risk score construction.
01
Fixed-Effects vs. Random-Effects Models
The two primary frameworks for combining GWAS summary statistics. Fixed-effects models assume a single true effect size across all cohorts and weight each study by the inverse of its variance. Random-effects models account for between-study heterogeneity, applying a more balanced weighting when effect sizes differ due to ancestry or phenotype definitions. The choice depends on the degree of Cochran's Q statistic heterogeneity.
02
Inverse-Variance Weighting
The standard method for combining per-variant effect estimates. Each study's beta coefficient is weighted by the reciprocal of its squared standard error, giving more precise estimates greater influence on the pooled result. This approach maximizes statistical power under the fixed-effects assumption and is the default in tools like METAL and PLINK.
03
Sample Overlap Correction
When cohorts share control participants or contain related individuals, standard meta-analysis inflates test statistics. LD Score regression intercept quantifies this inflation. Advanced methods like MR-MEGA and GENESIS model the covariance structure directly, preventing false positives from cryptic relatedness while retaining power from overlapping samples.
04
Trans-Ancestry Meta-Analysis
Combining GWAS from diverse populations improves fine-mapping resolution by exploiting differences in linkage disequilibrium patterns across ancestries. Methods like MR-MEGA model allelic heterogeneity as a function of genetic distance, while MANTRA uses Bayesian partition models. This approach directly addresses the European bias in GWAS and improves cross-ancestry PRS portability.
05
Heterogeneity Metrics
Key statistics for assessing consistency of genetic effects across cohorts:
- Cochran's Q: Tests whether observed between-study variance exceeds chance
- I² statistic: Quantifies the proportion of total variance attributable to heterogeneity (0-100%)
- Between-study variance (τ²): The estimated variance of true effect sizes across studies High heterogeneity may indicate genuine effect modification by ancestry or environment.
06
Genomic Control Correction
A post-hoc adjustment applied to meta-analysis results when residual population stratification inflates the genomic inflation factor (λ). Test statistics are divided by λ, conservatively correcting the distribution to match the null expectation. While simple, this method can over-correct when polygenicity—not bias—drives inflation, making LD Score regression intercept a preferred alternative.
MODEL ASSUMPTIONS
Fixed-Effects vs. Random-Effects Meta-Analysis
Comparison of the two primary statistical frameworks for combining GWAS summary statistics across cohorts, distinguished by their treatment of between-study heterogeneity.
| Feature | Fixed-Effects Model | Random-Effects Model | Notes |
|---|---|---|---|
Core Assumption | One true effect size shared across all studies | True effect sizes vary across studies, drawn from a distribution | |
Source of Variance | Within-study sampling error only | Within-study error + between-study heterogeneity (τ²) | |
Weighting Scheme | Inverse-variance weighting (1/SE²) | Inverse-variance weighting adjusted by τ² (1/(SE² + τ²)) | |
Heterogeneity Parameter (τ²) | Assumed to be zero | Estimated from data (e.g., DerSimonian-Laird, REML) | |
Applicability | Homogeneous studies with identical protocols | Heterogeneous studies with varying populations or designs | |
Statistical Power | Higher when heterogeneity is truly absent | Lower for detecting a common effect; higher generalizability | |
Summary Estimate Interpretation | Best estimate of the single common effect | Estimate of the mean of the distribution of true effects | |
Confidence Interval Width | Narrower | Wider (reflects uncertainty in τ²) | |
Common Estimator | Inverse-variance weighted (IVW) estimator | DerSimonian-Laird estimator | |
Cochran's Q Test | Used to test the null hypothesis of homogeneity (H₀: τ² = 0) | Significant Q (p < 0.10) supports use of random-effects | |
I² Statistic | Quantifies % of total variation due to heterogeneity; guides model choice | I² > 50% typically favors random-effects | |
GWAS Meta-Analysis Software | METAL (SCHEME STDERR), PLINK --meta-analysis | GWAMA, METASOFT, rareMETALS |
META-ANALYSIS IN GENOMICS
Frequently Asked Questions
Explore the statistical frameworks that combine GWAS summary statistics across cohorts to boost variant discovery power and build more robust, generalizable polygenic risk scores.
A GWAS meta-analysis is a statistical technique that combines summary-level association results from multiple independent genome-wide association studies to increase the effective sample size without requiring individual-level data sharing. By aggregating effect size estimates and standard errors across cohorts, meta-analysis boosts statistical power to detect variants with small effect sizes that would remain below the genome-wide significance threshold (p < 5×10⁻⁸) in any single study. The core principle leverages the fact that power scales with sample size: doubling the sample size through meta-analysis can detect effect sizes approximately 40% smaller. Common methods include fixed-effects models, which assume a single true effect across studies and weight each study by the inverse of its variance, and random-effects models, which account for between-study heterogeneity when effect sizes genuinely differ across populations. Software implementations like METAL and PLINK perform these calculations efficiently on hundreds of millions of variants, making meta-analysis the primary driver of variant discovery in complex trait genetics.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.
Enterprise searchRAGPermissions
Read more
Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.
AI agentsWorkflow automationGovernance
Read more
Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
AI integrationDecision supportModel routing
Read more
About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
LinkedIn
Limited slotsGet a Free AI Consultation
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us